Jecure Therapeutics, Inc. — Form D
Jecure Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-16. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-16
- Form: D
- Accession: 0001675100-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 4
- Date of first sale: 2018-07-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-316893
Issuer
- Name: Jecure Therapeutics, Inc.
- CIK: 0001698655
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 4757 Nexus Center Drive, Suite 150, SAN DIEGO, CA, 92121
- Phone: 619-541-8694
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Bradley Bolzon, Ph.D. | Director | San Diego, CA |
| Ariel Feldstein, M.D. | Director | San Diego, CA |
| Jeffrey Stafford, Ph.D. | Director | San Diego, CA |
| Thomas Woiwode, Ph.D. | Director | San Francisco, CA |
| Jeffrey Stafford, Ph.D. | Executive Officer | San Diego, CA |
| James Veal, Ph.D. | Executive Officer | San Diego, CA |
Other filings by this issuer (2)
More